← Back to feedRead original →
VERIFIEDET Markets·neutral
Alkem Labs shares in focus as Goldman, Morgan Stanley, others purchase stake in Rs 930-crore block deal
AI Summary
- ·Block deals worth Rs 930 crore involving 17.88 lakh Alkem Laboratories shares occurred at Rs 5,200 each.
- ·Promoter-linked entities sold their stake, while domestic mutual funds and foreign institutional investors bought shares.
- ·Alkem Laboratories launched semaglutide pre-filled syringes in India.